Abstract
In most underdeveloped regions of the world, especially the tropical areas, intestinal helminthiases present high prevalence rates, similar to those found a half-century ago (Botero, 1981). The varied and sometimes important symptomatology caused by these worms, the lowering of work efficiency, and the deterioration of nutritional status are deleterious consequences requiring efficient confrontation not only by traditional measures such as installation of latrines, potable water, wearing of shoes, instruction, and personal hygiene, but also by medical treatment to individuals or to affected populations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amato Neto, V., Sinto, T., Pedro, R.J., Levi, G.C., Tsukumo, M.K.K., de Moraes, V.M.C., and Correa, L. de L., 1978, Nossas observacoes iniciais sobre a eficacia do cambendazole no tratamento da estrongiloidiase, Rev. Inst. Med. Trop. 20:161–163.
Amato-Neto, V., Moreira, A.A.B., Campos, R., Lazzaro, E.S.M., Chiaramelli, M.C.G., Pinto, P.L.S., Da Silva, G.R., Nishioka, S., and de A. e Leite, R.M., 1983, Tratamento da ancilostomiase, ascaridiase e tricocefaliase por mejo do albendazol ou do mebendazol, Rev. Inst. Med. Trop. 25:294–299.
Baransky, M.C., Silva, A.F., Kotaka, P.I., Gomez, N.R., Giovannoni, M., and Telles, J.E.Q., 1978, Tratamento da estrongiloidiase humana com novo antihelmintico, o cambendazole. Estudo duplo cego, Rev. Inst. Med. Trop. Sao Paulo 20:213–218.
Beck, J.W., Saavedra, D., Anteil, G.J., and Tejeiros, B., 1959, The treatment of pinworm infections in humans (enterobiasis) with pyrvinium chloride and pyrvinium pamoate, Am.J. Trop. Med. Hyg. 8:349–352.
Botero, C.A., Calad, G.A., Cardona, E.A., Correa, D.H., and Gonzalez, C.M., 1984, Epidemiologia de las helmintiasis intestinales en una zona rural de Antioquia, Colombia (Control por tratamiento comunitario), Medicina Universidad Pontificia Bolivariana 3:65–76.
Botero, D., 1976, Clinical trial methodology in intestinal parasitic disease, Clin. Pharmacol. Ther. 19:630–637.
Botero, D., 1979, Posibilidades de control de las geohelmintiasis mediante tratamientos en masa, Bol. Chile. Parasitol. 34:39–43.
Botero, D., 1981, Persistence of the endemic intestinal parasitoses in Latin America, Bull. Pan. Am. Health Org. 15:241–248.
Botero, D., and Castano, A., 1973, Comparative study of pyrantel pamoate, bephenium hydroxinaphthoate and tetrachloroethylene in the treatment of Necator americanus infections, Am.J. Trop. Med. Hyg. 22:45–52.
Brugmans, J.P., Thienpont, D.C., Van Wijngaarden, I., Vanparijs, O.F., Schermans, V.L., and Lauwers, H.L., 1971, Mebendazole in enterobiasis. Radio-chemical and pilot clinical study in 1,278 subjects, J.A.M.A. 217:313–316.
Campbell, W.C., and Cuckler, A.C., 1969, Thiabendazole in the treatment and control in parasitic infections in man, Tex. Rep. Biol. Med. (Suppl. 2) 27:665–692.
Calvalho Filho, E., 1978, Strongyloidiasis. Clin. Gastroenterol. 7:179–200.
Chitchang, S., Leelayoova, S., and Piamjinda, T., 1983, Albendazole in the treatment of hookworm infestation in Thailand, J. Med. Assoc. Thailand 66:45–48.
Coulaud, J.P., Deluol, A.M., Cenac, J., and Rossignol, J.F., 1982, L’albendazole dans le traitement de la strongyloidose: à propos de 66 observations, Bull. Soc. Pathol. Exot. Fil. 75:530–533.
Davis, A., 1973, Drug Treatment of Intestinal Helminthiases, 125 pp., World Health Organization, Geneva.
Firth, M. (ed.), 1983, Albendazole in helminthiasis, in: International Congress Symposium Series, No. 57, Royal Society of Medicine, London.
Goodwin, L.G., 1980, New drugs for old diseases, Trans. R. Soc. Trop. Med. Hyg. 74:1–7.
Grove, D.I., 1982, Strongyloides ratti and S. stercoralis: The effects of thiabendazole, mebendazole and cambendazole in infected mice, Am. J. Trop. Med. Hyg. 31:469–476.
Grove, D.I., 1983, The effects of 22,23-dihydroavermectin B1 on Strongyloides ratti and S. stercoralis infections in mice, Ann. Trop. Med. Parasitol. 77:405–410.
Kan, S.P., 1983, The anthelmintic effects of flubendazole on Trichuris trichiura and Ascaris lumbricoides, Trans. R. Soc. Trop. Med. Hyg. 77:668–670.
Lee, E.L., Kyngkaran, N., Grieve, A.W., Robinson, M.J., and Dissanaike, A.S., 1976, Therapeutic evaluation of oxantel pamoate (l,4,5,6-tetrahydro-l-methyl-2-(trans-3-hydroxystyryl)pyrimidine pamoate) in severe Trichuris trichiura infection, Am. J. Trop. Med. Hyg. 25:563–567.
Moens, M., Dom, J., Burke, W.E., Schlossberg, S., and Schermans, V., 1978, Levamisole in ascariasis. A multicenter controlled evaluation, Am. J. Trop. Med. Hyg. 27:897–904.
Pawlowski, Z.S., 1983, Clinical aspects in man, in: Trichinella and Trichinosis (W. C. Campbell, ed.), pp. 367–401, Plenum Press, New York.
Peña-Chavarria, A., Swatzwelder, J.C., Villarejos, V.M., and Zeledon, R., 1973, Mebendazole an effective broad spectrum anthelmintic, Am. J. Trop. Med. Hyg. 22:592–595.
Pene, P., Mojon, M., Garin, J.P., Coulaud, J.P., and Rossignol, J.F., 1982, Albendazole: a new broad spectrum anthelmintic. Double blind multicenter clinical trial, Am. J. Trop. Med. Hyg. 31:263–266.
Renoux, G., Renoux, M., Teller, M.N., McMahon, S., and Gyillaumin, J.M., 1976, Potentiation of Tcell mediated immunity by levamisole, Clin. Exp. Immunol. 25:288–296.
Rossignol, J.F., and Coulaud, J.P., 1983, Summary of clinical trials worldwide (evaluation of albendazole in Europe, West Africa and Asia as a single-dose anthelmintic: report on 1455 patients), in: Albendazole in Helminthiasis (M. Firth, ed.), International Congress Symposium Series, No. 57, Royal Society of Medicine, London, pp. 19–27.
Rossignol, J.F., and Maisonneuve, H., 1983, Albendazole: Placebo-controlled study in 870 patients with intestinal helminthiasis, Trans. R. Soc. Trop. Med. Hyg. 17:707–711.
Sanati, A., and Ghadirian, E.G., 1971, Treatment of enterobiasis with pyrantel pamoate in Iran, J. Trop. Med. Hyg. 74:160–161.
Sargent, R.G., Savory, A.M., Mina, A., and Lee, P.R., 1974, A clinical evaluation of mebendazole in the treatment of trichuriasis, Am. J. Trop. Med. Hyg. 23:375–377.
Schenone, H., Galdames, M., Insunza, E., Jimenez, M., Romero, E., and Bloomfield, R., 1977, Flubendazol en el tratamiento de infecciones por nematodes intestinales en niños, Bol. Chil. Parasitol. 32:85–86.
Stephenson, L.S., Cromptom, E.W.T., Latham, M.C., Arnold, S.E., and Jansen, A.A.J., 1983, Evaluation of a four year project to control Ascaris infection in children in two Kenyan villages, J. Trop. Pediatr. 29:175–184.
Sturchler, D., 1982, Chemotherapy of human intestinal helminthiases: A review, with particular reference to community treatment, Adv. Pharmacol. Chemother. 19:129–154.
Thienpont, D., Brugmans, J., Abadi, K., and Tanamal, S., 1969, Tetramisole in the treatment of nematode infections of man, Am. J. Trop. Med. Hyg. 18:520–525.
Van den Bossche, H., 1981, Peculiar targets in anthelmintic chemotherapy, Biochem. Pharmacol. 29:1981–1990.
Van den Bossche, H., Rochette, F., and Horig, C., 1982, Mebendazole and related anthelmintics, Adv. Pharmacol, and Chemother. 19:67–128.
Wilson, K.H., and Kauffman, C.A., 1983, Persistent Strongyloides stercoralis in a blind loop of the bowel: successful treatment with mebendazole, Arch. Intern. Med. 143:357–358.
World Health Organization, 1981, Intestinal Protozoan and Helminthic Infections, Technical Report Series 666, World Health Organization, Geneva.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Botero, D. (1986). Nematode Infections of Man: Intestinal Infections. In: Campbell, W.C., Rew, R.S. (eds) Chemotherapy of Parasitic Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1233-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1233-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1235-2
Online ISBN: 978-1-4684-1233-8
eBook Packages: Springer Book Archive